FDA Expands RWE Partnership with Brigham and Women’s Hospital and Aetion

Aetion, Inc announced the FDA and Brigham and Women's Hospital have expanded their demonstration project. The first use of RWE to predict treatment safety and efficacy, and time researchers will estimate the results of randomized controlled trials that have not yet concluded.

Read more here.